These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24611576)

  • 1. Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy.
    Witting N; Mensah A; Køber L; Bundgaard H; Petri H; Duno M; Milea D; Vissing J
    Acta Neurol Scand; 2014 Aug; 130(2):125-30. PubMed ID: 24611576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
    van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
    J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and electrophysiologic features of oculopharyngeal muscular dystrophy: lack of evidence for an associated peripheral neuropathy.
    Jones LK; Harper CM
    Clin Neurophysiol; 2010 Jun; 121(6):870-3. PubMed ID: 20181517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint.
    Van Der Sluijs BM; Hoefsloot LH; Padberg GW; Van Der Maarel SM; Van Engelen BG
    J Neurol; 2003 Nov; 250(11):1307-12. PubMed ID: 14648146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.
    Youssof S
    Muscle Nerve; 2016 May; 53(5):694-9. PubMed ID: 26453481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
    Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
    Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oculopharyngeal muscular dystrophy among Bulgarian Jews: a new cluster?
    Blumen SC; Kesler A; Dabby R; Shalev S; Khayat M; Almog Y; Zoldan J; Benninger F; Drory VE; Gurevich M; Sadeh M; Brais B; Braverman I
    Isr Med Assoc J; 2013 Dec; 15(12):748-52. PubMed ID: 24449978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of impairments in oculopharyngeal muscular dystrophy.
    Brisson JD; Gagnon C; Brais B; Côté I; Mathieu J
    Muscle Nerve; 2020 Aug; 62(2):201-207. PubMed ID: 32270505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.
    Youssof S; Schrader R; Bear D; Morrison L
    Neuromuscul Disord; 2015 Mar; 25(3):238-46. PubMed ID: 25500011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cricopharyngeal myotomy in the treatment of oculopharyngeal muscular dystrophy.
    Gómez-Torres A; Abrante Jiménez A; Rivas Infante E; Menoyo Bueno A; Tirado Zamora I; Esteban Ortega F
    Acta Otorrinolaringol Esp; 2012; 63(6):465-9. PubMed ID: 22898142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swallow characteristics in patients with oculopharyngeal muscular dystrophy.
    Palmer PM; Neel AT; Sprouls G; Morrison L
    J Speech Lang Hear Res; 2010 Dec; 53(6):1567-78. PubMed ID: 20699340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of pelvic girdle and proximal leg muscles in early oculopharyngeal muscular dystrophy.
    van der Sluijs BM; Lassche S; Knuiman GJ; Kusters B; Heerschap A; Hopman M; Schreuder TH; van Engelen BGM; Voermans NC
    Neuromuscul Disord; 2017 Dec; 27(12):1099-1105. PubMed ID: 29102430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siblings with recessive oculopharyngeal muscular dystrophy.
    Hebbar S; Webberley MJ; Lunt P; Robinson DO
    Neuromuscul Disord; 2007 Mar; 17(3):254-7. PubMed ID: 17296297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed diagnosis of oculopharyngeal muscular dystrophy in Scotland.
    Agarwal PK; Mansfield DC; Mechan D; Al-Shahi Salman R; Davenport RJ; Connor M; Metcalfe R; Petty R
    Br J Ophthalmol; 2012 Feb; 96(2):281-3. PubMed ID: 21602480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phenotypic and genotypic features of Chinese patients with oculopharyngeal muscular dystrophy.
    Lin F; Yang K; Lin MT; Zheng FZ; Chen L; Ding YL; Ye ZX; Lin X; Wang N; Wang ZQ
    Ann Clin Transl Neurol; 2023 Mar; 10(3):426-439. PubMed ID: 36691350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: a pilot study.
    Bouazza B; Kratassiouk G; Gjata B; Perie S; Lacau St Guily J; Butler-Browne GS; Svinartchouk F
    Neuromuscul Disord; 2009 Mar; 19(3):199-206. PubMed ID: 19185491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes.
    Blumen SC; Bouchard JP; Brais B; Carasso RL; Paleacu D; Drory VE; Chantal S; Blumen N; Braverman I
    Neurology; 2009 Aug; 73(8):596-601. PubMed ID: 19704078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
    Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
    J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.